MRVL vs NKE: Which Is the Better Buy?

Side-by-side comparison of Marvell Technology, Inc. and NIKE, Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-04-16.
Marvell Technology, Inc. Β· Technology
$133.37
+25.2% upside to fair value
High Conviction Grade B
VS
NIKE, Inc. Β· Consumer Cyclical
$42.62
+45.5% upside to fair value
Med Conviction Grade B+
QuantHub Verdict
NKE has more upside to fair value (+45.5%). NKE trades at a lower forward P/E (27.9x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric MRVL NKE
Current Price $133.37 $42.62
Fair Value Estimate $167.00 $62.00
Upside to Fair Value +25.2% +45.5%
Market Cap $116.6B $63.0B
Forward P/E 42.4x 27.9x
EV / EBITDA β€” 20.7x
Price / Sales 14.2x 1.4x
Price / FCF 83.7x 19.4x
Revenue Growth YoY +7.0% -9.8%
Gross Margin 50.1% 42.7%
Operating Margin 16.3% 8.0%
Return on Equity 19.4% 24.4%
Dividend Yield β€” 3.8%
FCF Yield 1.2% 5.2%
Analyst Consensus Strong Buy Buy
Investment Thesis
MRVL β€” Marvell Technology, Inc.
Marvell Technology designs semiconductors for data infrastructure, including storage, networking, connectivity for AI, cloud, 5G, and automotive; the business excels with a dominant Data Center segment driving 42% FY2026 revenue growth to $8.2B amid AI demand, strong leadership under long-tenured CEO Matt Murphy, and robust 50% gross margins, though offset by earnings decline and non-Data Center …
NKE β€” NIKE, Inc.
Nike is the world's largest athletic footwear and apparel company with $46.3B in FY2025 revenue, operating across 190+ countries with the Nike, Jordan, and Converse brands. The stock trades near its 9-year low at $42.62 after an 11% single-day crash following a Q3 FY2026 earnings report that showed 35% net income decline and weak Q4 guidance calling for a further 2-4% revenue decline. FY2025 reve…
Accumulation Zones
Metric MRVL NKE
Zone Low $125.00 $44.00
Zone High $142.00 $50.00
In Buy Zone? Yes Yes
← MRVL Research    NKE Research β†’    All Research